Nluc Reporter Cell Line - HOS

The HOS cell line, derived from human osteosarcoma, is a well-established model widely used in cancer research and biomedical studies. Originally isolated from a 13-year-old female patient, this epithelial-like adherent cell line has been extensively used to study bone biology, tumor progression, and metastatic mechanisms. HOS cells exhibit typical characteristics of osteosarcoma, including rapid proliferation, invasive potential, and responsiveness to growth factors. They are an important tool for studying cell signaling pathways, drug resistance, and the effects of therapeutic agents on bone malignancies. Due to their stable characteristics and good reproducibility, HOS cells are widely used in cytotoxicity assays, gene expression studies, and molecular biology experiments, providing valuable insights into cancer pathophysiology and treatment strategies.

The Nluc reporter cell line - HOS integrates the highly sensitive Nluc luciferase reporter system into the HOS cell line, enabling advanced real-time monitoring of cellular activity. This engineered cell line is particularly valuable for high-throughput screening (HTS) applications, such as drug discovery and toxicology studies, allowing for quantitative analysis of compound effects on gene expression, promoter activation, and signal transduction pathways with extremely high signal-to-noise ratios. Researchers utilize this model to track dynamic biological processes, such as NF-κB signaling or viral infection responses, using luminescence-based methods with minimal sample requirements. Furthermore, the stability and high brightness of the Nluc reporter gene facilitate long-term studies of live cells, enabling non-invasive, real-time tracking of cellular events.